smoldering myeloma Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (3)

Phase 3 (2)
Unknown (1)

Interventional (3)

Sanofi (2)
City of Hope Medical Center (1)

No (3)

No (3)

Adult (18+) (3)

I am/have/had

I am/have/hadsmoldering myeloma

I am/have/hadcancer

I am/have/hadmultiple myeloma

I am/have/hadbone marrow plasma cells

I am/have/hadneutrophil count

I am/have/hadplatelet count

I am/have/hadhepatitis

I am/have/hadabsolute neutrophil count

I am/have/hadhysterectomy

I am/have/hadplatelet transfusions

I am/have/hadoophorectomy

I am/have/hadbilateral oophorectomy

I am/have/hadremoval of ovaries

I am/have/hadsmoldering multiple myeloma

I am/have/hadresidual tumor

I am/have/hadspot test

I am/have/hadtuberculosis

I am/have/hadminimal residual disease

I am/have/hadbone marrow procedure

I am/have/hadresidual disease

added new label for I am/have/had

more

I am looking for

I am looking forlenalidomide

I am looking fordexamethasone

I am looking forprednisone

I am looking forisatuximab

I am looking forleflunomide

I am looking forabortifacient

I am looking forbeta-human chorionic gonadotropin

I am looking foranti-inflammatory drugs

added new label for I am looking for

more

Advanced Filters

Loading...

Found 162 clinical trials

Multi-country trial
Phase 3
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Family Medicine
Recruiting

Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma

Primary Objectives: Safety run-in: To confirm the recommended dose of isatuximab when combined with lenalidomide and dexamethasone in participants with high-risk smoldering multiple myeloma (SMM) Randomized Phase 3: To demonstrate the clinical benefit of isatuximab in combination with lenalidomide and dexamethasone in the prolongation of progression-free survival when compared to …

multiple myeloma

smoldering myeloma

residual tumor

dexamethasone

lenalidomide

0 views
24 Nov, 2025
16 locations

Multi-country trial
Phase 3
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Family Medicine
Recruiting

Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma

Primary Objectives: Safety run-in: To confirm the recommended dose of isatuximab when combined with lenalidomide and dexamethasone in participants with high-risk smoldering multiple myeloma (SMM) Randomized Phase 3: To demonstrate the clinical benefit of isatuximab in combination with lenalidomide and dexamethasone in the prolongation of progression-free survival when compared to …

multiple myeloma

smoldering myeloma

residual tumor

dexamethasone

lenalidomide

0 views
24 Nov, 2025
16 locations

12
13
14
15
16
17

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2026 All rights reserved.